# Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma

Article · Moshe Sade-Feldman, Keren Yizhak, Stacey L. Bjorgaard, John P. Ray, Carl G. de Boer, Russell William Jenkins, David Lieb, Jonathan H. Chen, Dennie Tompers Frederick, Michal Barzily-Rokni, Samuel S. Freeman, Alexandre Reuben, Paul Hoover, Alexandra–Chloé Villani, Elena V. Ivanova, Andrew J. Portell, Patrick Hall Lizotte, Amir Reza Aref, Jean-Pierre Eliane, Marc R. Hammond, Hans Vitzthum, Shauna M. Blackmon, Bo Li, Vancheswaran Gopalakrishnan, Sangeetha Meda Reddy and 10 more

- Archive id: doi:10.1016/j.cell.2018.10.038
- Published: 2018-11-01
- Venue: Cell
- DOI: https://doi.org/10.1016/j.cell.2018.10.038
- PMID: 30388456
- Citations: 2,052
- Source URL: https://doi.org/10.1016/j.cell.2018.10.038
- PDF: http://www.cell.com/article/S0092867418313941/pdf
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [Cancer Immunotherapy](https://space-kitty.com/topics/cancer-immunotherapy)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.